Optimum Therap 
Welcome,         Profile    Billing    Logout  
 1 Product   84 Diseases  1 Product   3 Trials   654 News 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Germanin (suramin) / Optimum Therap
NCT06058962: Double Blind Trial in Children With Autism Spectrum Disorder

Completed
2
52
US
Suramin Sodium, Placebo
Paxmedica
Autism Spectrum Disorder
01/21
03/21
NCT04496596: Study of Suramin in Subjects With Furosemide-Resistant AKI

Active, not recruiting
2
68
US
Suramin, Placebo
Rediscovery Life Sciences
Acute Kidney Injury
04/23
12/23
STAT-2A, NCT06866275: Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)

Recruiting
2
45
US
KZ101, Suramin, Suramin sodium, Placebo, Saline
Children's Hospital of Orange County, Kuzani Pharmaceuticals, Inc.
Autism Spectrum Disorder (ASD)
04/28
04/28
ChiCTR2000030029: A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19)

Not yet recruiting
N/A
20
China
Suramin( IV.)
The First Affiliated Hospital of Zhejiang University School of Medicine; The First Affiliated Hospital, Zhejiang University School of Medicine, Self-financing
Novel Coronavirus Pneumonia (COVID-19)
 
 
ChiCTR2100042004: A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19)

Suspended
N/A
20
 
Suramin (IV.)
Deyang People's Hospital; Deyang people's Hospital, Financial appropriation
Novel Coronavirus Pneumonia (COVID-19)
 
 
NCT06060600: A Retrospective Analysis of Suramin Treatment for Stage 1 TBR

Completed
N/A
345
US
Paxmedica
Trypanosoma Brucei Rhodesiense; Infection
08/23
08/23
TPM001 / Optimum Therap
No trials found
instant release paclitaxel nanoparticles / Optimum Therap
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Germanin (suramin) / Optimum Therap
NCT06058962: Double Blind Trial in Children With Autism Spectrum Disorder

Completed
2
52
US
Suramin Sodium, Placebo
Paxmedica
Autism Spectrum Disorder
01/21
03/21
NCT04496596: Study of Suramin in Subjects With Furosemide-Resistant AKI

Active, not recruiting
2
68
US
Suramin, Placebo
Rediscovery Life Sciences
Acute Kidney Injury
04/23
12/23
STAT-2A, NCT06866275: Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)

Recruiting
2
45
US
KZ101, Suramin, Suramin sodium, Placebo, Saline
Children's Hospital of Orange County, Kuzani Pharmaceuticals, Inc.
Autism Spectrum Disorder (ASD)
04/28
04/28
ChiCTR2000030029: A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19)

Not yet recruiting
N/A
20
China
Suramin( IV.)
The First Affiliated Hospital of Zhejiang University School of Medicine; The First Affiliated Hospital, Zhejiang University School of Medicine, Self-financing
Novel Coronavirus Pneumonia (COVID-19)
 
 
ChiCTR2100042004: A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19)

Suspended
N/A
20
 
Suramin (IV.)
Deyang People's Hospital; Deyang people's Hospital, Financial appropriation
Novel Coronavirus Pneumonia (COVID-19)
 
 
NCT06060600: A Retrospective Analysis of Suramin Treatment for Stage 1 TBR

Completed
N/A
345
US
Paxmedica
Trypanosoma Brucei Rhodesiense; Infection
08/23
08/23
TPM001 / Optimum Therap
No trials found
instant release paclitaxel nanoparticles / Optimum Therap
No trials found

Download Options